The chemical class known as GAL4-TA Activators encompasses a diverse range of compounds that interact with the GAL4 transcriptional activator system in yeast, a model organism extensively utilized in genetic research. This class includes galactose, a primary regulator of GAL4, which activates the transcription factor by alleviating GAL80-mediated inhibition. This direct interaction highlights a unique aspect of metabolic control over gene expression. Galactose analogs like 2-Deoxygalactose and Methyl-β-D-galactoside also feature in this class, offering modulatory effects on the GAL4 system by mimicking the structure and function of galactose.
Expanding beyond direct activators, the class encompasses compounds like D-Galactonolactone, Forskolin, and IBMX. D-Galactonolactone, another galactose analog, could interact with GAL4 regulatory pathways, altering its transcriptional activity. Forskolin and IBMX function by increasing intracellular cAMP levels, thereby influencing cellular signaling pathways that could intersect with GAL4 regulation. Lithium Chloride, which inhibits GSK-3, a kinase involved in multiple signaling pathways, represents a broader approach to modulating cellular processes that may impact GAL4 activity. The inclusion of PD98059 and LY294002, inhibitors of the MEK and PI3K pathways respectively, indicates the ability for altering MAPK and PI3K/Akt signaling pathways, which can have downstream effects on GAL4 function. Lastly, Sodium Butyrate, a histone deacetylase inhibitor, affects chromatin structure and gene expression, providing an epigenetic angle to the modulation of GAL4-mediated transcription. This diverse array of compounds underlines the intricate network of cellular signaling and metabolic pathways that can converge on a pivotal transcription factor like GAL4, demonstrating the complexity and interconnectivity inherent in cellular regulatory mechanisms.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
D-Galactose | 59-23-4 | sc-202564 | 100 g | $224.00 | 4 | |
Direct activator of the GAL4 system, as its presence alleviates the inhibition of GAL4 by GAL80. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $65.00 $210.00 | 26 | |
A galactose analog that may interact with the GAL4 system, possibly affecting GAL4 activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Activates adenylate cyclase, increasing cAMP levels, which could indirectly affect cellular signaling pathways related to GAL4 activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
A phosphodiesterase inhibitor, increases cAMP levels, potentially affecting signaling pathways linked to GAL4 activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3, a kinase involved in many signaling pathways, potentially affecting pathways that intersect with GAL4 regulation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
An inhibitor of MEK, which is part of the MAPK pathway. By altering MAPK signaling, it may indirectly influence GAL4 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor, could impact signaling pathways that indirectly modulate GAL4 activity, especially in energy metabolism. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
A histone deacetylase inhibitor, affects chromatin structure and gene expression, potentially influencing GAL4-mediated transcription. | ||||||